Advertisement
ASPI vs GEVO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASPI is a Hold and GEVO is a Hold.
ASPI sees its Stochastic Oscillator recovers from oversold territory
On November 06, 2026, the Stochastic Oscillator for ASPI moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 49 instances where the indicator left the oversold zone. In 48 of the 49 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ASPI's RSI Oscillator exited the oversold zone, 24 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ASPI as a result. In 63 of 66 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for ASPI just turned positive on October 27, 2026. Looking at past instances where ASPI's MACD turned positive, the stock continued to rise in 27 of 29 cases over the following month. The odds of a continued upward trend are 90%.
Following a +5.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASPI advanced for three days, in 195 of 210 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
ASPI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASPI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for ASPI entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.202) is normal, around the industry mean (2.284). P/E Ratio (-1.634) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (11.062) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. ASPI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASPI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
GEVO's Stochastic Oscillator reaches into overbought zone
The Stochastic Oscillator for GEVO moved into overbought territory on November 06, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GEVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
GEVO broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GEVO entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GEVO's RSI Indicator exited the oversold zone, 28 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on GEVO as a result. In 74 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for GEVO just turned positive on October 27, 2026. Looking at past instances where GEVO's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.
GEVO moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +9.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where GEVO advanced for three days, in 186 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.258) is normal, around the industry mean (2.284). P/E Ratio (-1.544) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (2.012) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. GEVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
GEVO | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 38 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 60 | |
P/E GROWTH RATING 1..100 | 23 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ASPI | GEVO | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 83% | 3 days ago 85% |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 90% | 3 days ago 80% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 81% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 82% |
| TrendMonth ODDS (%) | 3 days ago 88% | 3 days ago 79% |
| Advances ODDS (%) | 13 days ago 90% | 5 days ago 84% |
| Declines ODDS (%) | 6 days ago 86% | 28 days ago 83% |
| BollingerBands ODDS (%) | 3 days ago 87% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 89% | 3 days ago 89% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASPI’s FA Score shows that 1 FA rating(s) are green while GEVO’s FA Score has 1 green FA rating(s).
- ASPI’s FA Score: 1 green, 4 red.
- GEVO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASPI’s TA Score shows that 6 TA indicator(s) are bullish while GEVO’s TA Score has 5 bullish TA indicator(s).
- ASPI’s TA Score: 6 bullish, 2 bearish.
- GEVO’s TA Score: 5 bullish, 4 bearish.
Price Growth
ASPI (@Chemicals: Specialty) experienced а +2.72% price change this week, while GEVO (@Chemicals: Specialty) price change was +11.20% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -2.51%. For the same industry, the average monthly price growth was -4.65%, and the average quarterly price growth was -10.56%.
Reported Earning Dates
ASPI is expected to report earnings on Nov 18, 2026.
GEVO is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Chemicals: Specialty (-2.51% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
Advertisement
GEVO and
Correlation & Price change
A.I.dvisor indicates that over the last year, GEVO has been loosely correlated with ASPI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GEVO jumps, then ASPI could also see price increases.
| Ticker / NAME | Correlation To GEVO | 1D Price Change % | ||
|---|---|---|---|---|
| GEVO | 100% | +13.93% | ||
| ASPI - GEVO | 38% Loosely correlated | +20.64% | ||
| RPC - GEVO | 38% Loosely correlated | -0.82% | ||
| AMTX - GEVO | 37% Loosely correlated | -6.36% | ||
| SSL - GEVO | 28% Poorly correlated | -2.37% | ||
| GPRE - GEVO | 28% Poorly correlated | -3.43% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PYZ | 109.59 | 0.90 | +0.83% |
| Invesco Dorsey Wright Basic Materials Momentum ETF (PYZ) | |||
| TSME | 44.19 | 0.19 | +0.43% |
| Thrivent Small-Mid Cap Equity ETF (TSME) | |||
| RCS | 5.02 | N/A | N/A |
| PIMCO STRATEGIC Income FUND | |||
| KPDD | 4.86 | N/A | N/A |
| KraneShares 2x Long PDD Daily ETF (KPDD) | |||
| XLY | 117.58 | -0.06 | -0.05% |
| State Street Consumer Discretionary Select Sector SPDR ETF (XLY) | |||